ClinicalTrials.gg
Not yet recruitingNCT07849699OFLNUpdated Oct 5, 2026

Implementing Stepped Financial and Legal Navigation to Mitigate Financial Toxicity in Adolescent and Young Adult Cancer Patients Oncology Financial and Legal Navigation (OFLN)

An interventional study of Oncology Financial and Legal Navigation (OFLN) Stepped: Low Intensity and Oncology Financial and Legal Navigation (OFLN) Standard in Financial Toxicity, Cancer and Adolescent, sponsored by University of Louisville. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 39 Years. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by University of Louisville · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 5, 2026Primary outcomes revisedInterventions changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
294
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 59 studies in Financial Stress with a site in United States — 19 open to participants now, 26 under way, none of them phase 3. Financial Stress · United States.

Planned enrollment
10th of 51
294 · median 70
Started
2027
with 1 other
No phase
51 of 59
15 open now
Primary completion
2030-12
later than 25 of 25 live
Registered
58th of 59
by date

Among the 59 studies in Financial Stress with a site in United States, this one is the 10th largest by planned enrollment of the 51 interventional ones that give a count, is one of 2 that started in 2027, is one of 51 with no phase, reaches primary completion later than 25 of the 25 other live ones, and was the 58th registered.

Financial Stress

100 studies on the registry are indexed under Financial Stress; 34 are open to participants now.

Browse Financial Stress studies →

Open to participants now

19 of the 59 studies in Financial Stress with a site in United States are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 24 Financial Stress studies recruiting now, 17 (71%) set no upper age limit and 6 (25%) stop at 75 or younger; 7 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 39 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Financial Stress with a site in United States, or all of them as a file.
02

Study summary

The overall objective of this study is to test the effectiveness and implementability of stepped Oncology Financial and Legal Navigation (OFLN) in a noninferiority randomized controlled trial (RCT) using a hybrid type 1 (effectiveness-implementation) design.

Read the detailed description

The purpose of this study is to help with any financial and legal needs you may have, which will be provided through an Oncology Financial and Legal Navigation (OFLN) program. This is a randomized study, which means that after you agree to participate in this study, you will be randomly selected, like a flip of a coin, to receive either 1) OFLN A - Stepped Intervention or 2) OFLN B - Standard Intervention. The Stepped Intervention will provide a low and high intensity OFLN. The Standard Intervention will only provide high intensity OFLN. The low- intensity OFLN will include a personalized self-managed navigation program, while the high intensity OFLN will be guided by a navigator. Regardless of which OFLN intervention you are assigned to, you will receive assistance with your financial/legal needs. By participating in this program, you will be asked to work closely with study team at the University of Louisville (UofL) Health Brown Cancer Center and Triage Cancer-a financial/legal navigation program to help address your needs.

03

Conditions studied

  • Financial Toxicity
  • Cancer
  • Adolescent
  • Young Adult Cancer Survivors

Keywords

  • Financial toxicity
  • Adolescent and Young Adult
  • Oncology financial and legal navigation
  • Hardship
04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newly diagnosed with cancer within the past 12 months
  • Able to read and speak English or Spanish
  • Actively receiving healthcare at the University of Louisville

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairments that would interfere with participation
  • Unable to read and speak English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
294 participants (estimated)

Study arms

  • Experimental
    Oncology Financial and Legal Navigation (OFLN) Stepped Arm

    Once randomized to the stepped Oncology Financial and Legal Navigation (OFLN) intervention arm, patients with a lower financial toxicity at baseline will be assigned to the low-intensity OFLN and patients with high financial toxicity will be assigned to the high-intensity OFLN.

    Other: Oncology Financial and Legal Navigation (OFLN) Stepped: Low Intensity · Other: Oncology Financial and Legal Navigation (OFLN) Stepped: High-Intensity

  • Active comparator
    Oncology Financial and Legal Navigation (OFLN) Standard

    Patients randomized to the standard Oncology Financial and Legal Navigation (OFLN) arm will receive standard navigation services which includes access to a virtual, navigator-led program.

    Other: Oncology Financial and Legal Navigation (OFLN) Standard

Interventions

  • OtherOncology Financial and Legal Navigation (OFLN) Stepped: Low Intensity

    Baseline needs will be reviewed by Triage Cancer navigators who will build and personalize a self-managed navigation program and mail introductory packets and resource materials to participant along with an email link with personalized program which includes a customized package of Triage Cancer's educational resources (e.g., webinars, quick guides, interactive tools. Participants will have roughly 4 weeks to complete their program, lasting \~4 hours, and any self-directed activities. Completion verification and engagement tracking questions are included in weekly check-in surveys to monitor progress. Following each 6-week screening, participants whose financial toxicity (FT) scores remain stable or improve will continue to receive an email with resources customized to newly identified needs until 30 weeks. Participants whose financial toxicity (FT) worsens and who meet criteria for stepping up following screenings (within the 30-week period) will be stepped into the high intensity arm.

  • OtherOncology Financial and Legal Navigation (OFLN) Standard

    Once randomized in the standard Oncology Financial and Legal Navigation (OFLN) arm, participants will be contacted by Triage Cancer navigators via email to schedule an initial phone consultation to review needs and collect pertinent information on insurance and employment, income, billing and other details to help connect participants with appropriate resources. Triage Cancer navigators will meet with all enrolled participants for a minimum of 6 phone/video call appointments starting with an initial consultation at baseline and follow-up appointments every 6 weeks following financial toxicity screenings, and as needed. All participants will receive navigation services for 30 weeks. Additional intensive legal services (i.e., legal counseling or representation) that require a jurisdiction-specific licensed lawyers will be provided by the research team's supervising attorney.

  • OtherOncology Financial and Legal Navigation (OFLN) Stepped: High-Intensity

    Once enrolled in the high-intensity Oncology Financial and Legal Navigation (OFLN) arm, participants will be contacted by Triage Cancer navigators via email to schedule an initial phone consultation to review needs and collect pertinent information on insurance and employment, income, billing and other details to help connect participants with appropriate resources. Triage Cancer navigators will meet with all enrolled participants for a minimum of 6 phone/videocall appointments starting with an initial consultation at baseline and follow-up appointments every 6 weeks following financial toxicity screenings, and as needed. All participants will receive navigation services for 30 weeks. Additional intensive legal services (i.e., legal counseling or representation) that require a jurisdiction-specific licensed lawyers will be provided by the research team's supervising attorney.

06

What researchers measure

Primary outcomes

  1. Change in Financial Toxicity: Psychological Response

    Financial toxicity (psychological response) will be measured using the 11-item Comprehensive Score for Financial Toxicity (COST) that measures emotional aspects of financial hardship (financial toxicity) among cancer patients. Each item is scored on a 5-point ordinal scale ranging from 0='Not at all' to 4='Very much. Lower values indicate greater financial toxicity.

    Time frame: From baseline to 12-, 30- (primary), and 48-weeks; and also measured every 6 weeks as screener

  2. Implementation Outcomes

    Intervention acceptability, appropriateness and feasibility will be measured using the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM) with 12 items total, 3 subscales (4 items per subscale). Each item is rated on a 5-point Likert scale, with each subscale scored by summing the four items to yield a possible score ranging from 4 to 20. Higher scores indicate greater intervention acceptability, appropriateness, or feasibility, respectively.

    Time frame: Measured at 30-weeks and 48-weeks

Secondary outcomes

  1. Change in Financial Toxicity: Material Burden

    Financial toxicity (material burden) will be measured using the 15-item Economic Strain and Resilience in Cancer (ENRICh) scale which assesses overall financial toxicity across three subdomains: material burden, coping burden, and psychological distress. Items are scored on a 0-10 scale, with subdomain scores ranging from 0 to 10, where 0 indicates the least financial burden and 10 indicates the greatest financial burden. Higher material burden scores indicate greater financial hardship, including greater financial depletion related to out-of-pocket costs, use of savings, debt, and lost income.

    Time frame: Baseline to 12-, 30-, and 48-weeks

  2. Change in Financial Toxicity: Coping Burden

    Financial toxicity (coping burden) will be measured using the 15-item Economic Strain and Resilience in Cancer (ENRICh) scale which assesses overall financial toxicity across three subdomains: material burden, coping burden, and psychological distress. Items are scored on a 0-10 scale, with subdomain scores ranging from 0 to 10, where 0 indicates the least financial burden and 10 indicates the greatest financial burden. Higher material burden scores indicate greater financial hardship, including greater financial depletion related to out-of-pocket costs, use of savings, debt, and lost income.

    Time frame: Baseline to 12-, 30- and 48-weeks

  3. Change in Cost-related Health Literacy

    Cost-related health literacy will be measured using the 21-item Health Insurance Literacy Measure (HILM), which assesses confidence and health insurance-related behaviors related to choosing and using health insurance. The HILM includes four subscales: confidence in choosing health insurance, comparing health insurance plans, confidence in using health insurance, and being proactive in using health insurance. Items are rated on 4-point ordinal scales, with a total score ranging from 21 to 84. Higher scores indicate greater health insurance literacy, including greater confidence and greater likelihood of engaging in health insurance-literate behaviors. Cost-related health literacy will also be measured using a single item, yes/no question "Did you ever have a problem understanding health insurance or medical bills related to your cancer, its treatment, or the lasting effects of that treatment?"

    Time frame: From baseline to 12-, 30-, and 48-weeks

  4. Change in Participant Quality of Life

    Quality of life will be assessed using the 7-item Functional Assessment of Cancer Therapy-General (FACT-G7), which assesses physical, emotional, and functional well-being over the past 7 days. Items are rated on a 5-point Likert-type scale from 0 (not at all) to 4 (very much), with negatively worded items reverse-scored. Total scores range from 0 to 28, with higher scores indicating better quality of life.

    Time frame: Baseline to 12-, 30-, and 48-weeks.

  5. Change in Participant Quality of Life (Anxiety)

    Anxiety was measured using the 4-item Patient-Reported Outcomes Measurement Information System PROMIS® Anxiety short form. Scores range from 4 to 20. Higher scores indicate more of the construct being measured.

    Time frame: Baseline to 12-, 30- and 48-weeks

  6. Changes in Participant Quality of Life (Depression)

    Depression was measured using the 6-item Patient-Reported Outcomes Measurement Information System PROMIS® Depression Short Form. Scores range from 6 to 30. Higher scores indicate more of the construct being measured.

    Time frame: Baseline to 12-, 30- and 48-weeks.

  7. Change in Distress

    Distress will be measured using the National Comprehensive Cancer Network's (NCCN) 1-item Distress Thermometer and its accompanying 39-item problem list. A cutoff score of 4 indicates clinically elevated distress levels.

    Time frame: Baseline to 12-, 30-, and 48-weeks. Also used as a 6-week screener.

  8. Financial Savings

    Financial savings will be measured by assessing the amount of money saved per patient as result of participating in the intervention including grants and financial assistance received, total charges, financial assistance adjustments, insurance payments, and insurance charges.

    Time frame: Measured at 30- and 48-weeks.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2027; primary completion for Dec 2030, 46 months later.

Of 52 non-industry interventional studies with no phase under Financial Stress, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 40. This study's planned 46 months is above that.

Counting every sponsor, half of 52 studies reached it within 20 months; a quarter within 13 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2026
First posted
Sep 30, 2026
StartEst.
Feb 1, 2027
Primary completionEst.
Dec 1, 2030
CompletionEst.
Jun 1, 2031
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Interventions
Added Oncology Financial and Legal Navigation (OFLN) Stepped: Low Intensity·Oncology Financial and Legal Navigation (OFLN) Standard·Oncology Financial and Legal Navigation (OFLN) Stepped: High-Intensity; removed OFLN Stepped: Low Intensity·OFLN Standard·OFLN Stepped: High-Intensity. Arms added: Oncology Financial and Legal Navigation (OFLN) Stepped Arm·Oncology Financial and Legal Navigation (OFLN) Standard; arms removed: OFLN Stepped Arm·OFLN Standard
Oct 5, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionImplementation Outcomes: how it is measured was reworded
Oct 5, 2026
Secondary outcomes
4 description edited
What changed in the outcomes
  • DescriptionChange in Cost-related Health Literacy: how it is measured was reworded
  • DescriptionChange in Financial Toxicity: Coping Burden: how it is measured was reworded
  • DescriptionChange in Financial Toxicity: Material Burden: how it is measured was reworded
  • DescriptionChange in Participant Quality of Life: how it is measured was reworded
Oct 5, 2026
Registered
First appeared on the registry
Sep 30, 2026
Show all 2 updates
  1. Oct 5, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionImplementation Outcomes: how it is measured was reworded
    Secondary outcomes 4 description edited
    What changed in the outcomes
    • DescriptionChange in Cost-related Health Literacy: how it is measured was reworded
    • DescriptionChange in Financial Toxicity: Coping Burden: how it is measured was reworded
    • DescriptionChange in Financial Toxicity: Material Burden: how it is measured was reworded
    • DescriptionChange in Participant Quality of Life: how it is measured was reworded
    Interventions Added Oncology Financial and Legal Navigation (OFLN) Stepped: Low Intensity·Oncology Financial and Legal Navigation (OFLN) Standard·Oncology Financial and Legal Navigation (OFLN) Stepped: High-Intensity; removed OFLN Stepped: Low Intensity·OFLN Standard·OFLN Stepped: High-Intensity. Arms added: Oncology Financial and Legal Navigation (OFLN) Stepped Arm·Oncology Financial and Legal Navigation (OFLN) Standard; arms removed: OFLN Stepped Arm·OFLN Standard
    + 4 other changes: index terms, description, conditions and design details
  2. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07849699
Collaborators
National Institutes of Health (NIH), James Graham Brown Cancer Center
Responsible party
Jean Edward (Professor, Associate Dean for Faculty Development and Mentoring School of Nursing; Deputy Director of Nursing Research, Brown Cancer Center, University of Louisville) — Principal investigator
First posted
Sep 30, 2026
Start date
Feb 1, 2027 (estimated)
Primary completion
Dec 1, 2030 (estimated)
Completion
Jun 1, 2031 (estimated)
Last update
Oct 5, 2026

Study contacts

Jean Edward, PhD, RN, FAAN
Contact
jean.edward@louisville.edu
502-852-4356
Jean Edward, PhD, RN, FAAN
principal investigator · University of Louisville-Brown Cancer Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion